ALKS Alkermes plc
$44.32▼ -0.27%
Healthcare
Other
Volume 1.32M
Avg Volume (10D) 1.87M
Key Metrics & Fundamentals
Market Cap
$7.44B
P/E Ratio
116.6
Div Yield
0.00%
52W Range
27.00 - 55.67
% vs 50 MA
0.07%
% vs 200 MA
10.13%
RSI-14
57.1
MACD Histogram
+0.6300
Beta (1Y vs SPY)
0.80
Free Cash Flow
-$169.83M
Gross Rev
$392.91M
Gross Profit
$331.33M
EBITDA
-$21.61M
COGS
$61.58M
Operating Exp
$379.61M
Operating Income
-$48.28M
EBIT
-$48.28M
Pretax Income
-$61.93M
Net Income
-$66.48M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
Earnings Preview: Tarsus Pharmaceuticals, Inc. (TARS) Q3 Earnings Expected to Decline
Zacks · Oct 27, 2026 9:00 AM ET
Alkermes to Report Third Quarter Financial Results on November 3, 2026
Business Wire · Oct 20, 2026 4:00 PM ET
Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline
Zacks · Oct 20, 2026 9:00 AM ET
What First Trust NYSE Arca Biotech (FBT) Bought: Tarsus Leads on Oct. 16
GuruFocus.com · Oct 20, 2026 7:04 AM ET
Workday downgraded, Fox Corp. upgraded: Wall Street's top analyst calls
The Fly · Oct 16, 2026 9:38 AM ET
HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
Zacks · Oct 16, 2026 7:12 AM ET
Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at Sleep Europe 2026, Underscoring Leadership in Sleep Medicine Research
Business Wire · Oct 13, 2026 7:00 AM ET
4 CNS Drug Stocks Worth Watching This World Mental Health Day
Zacks · Oct 9, 2026 9:28 AM ET
Alkermes (ALKS) Holds To Its Narrative, Is The Pullback A Buying Opportunity?
Simply Wall St. · Oct 9, 2026 5:13 AM ET
Why Baird Sees Promising Growth Potential in Alkermes plc (ALKS)
Insider Monkey · Oct 5, 2026 9:48 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See ALKS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.